I hesitate to say this because I'm not a medical person, I don't think I'm far off
the mark but what I say might need some polishing.......
In efti/keytruda trials efti encourages the immune system to release monocytes
that keytruda previously couldn't reach for treatment...Monocytes are a type
of white blood cells.....This is the basis of our combo trials with merck and keytruda
and if it can be proven that efti has a broad success rate with allowing keytruda access
to targeted cells it couldn't get at solo, guess what?...we're in the money.....
I hesitate to say this because I'm not a medical person, I don't...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.020(7.02%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 31.0¢ | 29.0¢ | $1.171M | 3.900M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 101067 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 8068 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
